Abstract:Abstract A 66-year-old man was referred urgently to dermatology from ophthalmology with a short history of developing multiple pigmented lesions on the trunk and in the axillae, the concern being that he had developed a malignant melanoma. He had been under their care for almost a year with a history of a subacute decline in vision in both eyes leading to ‘tunnel vision’. His medical history was complex and included acute myeloid leukaemia secondary to myelodysplastic syndrome treated with fludarabine, melphalan and alemtuzumab (FMA) reduced-intensity sibling allograft. Following bone marrow transplant and chemotherapy, he had post-transplant complications including cytomegalovirus reactivation, cytopenia secondary to splenomegaly, and possible graft-versus-host disease (bronchiolitis obliterans and brachial plexitis). He had presented to ophthalmology with his vision at 6/12 and 6/9 in the right and left eye, respectively. On examination, there were poorly reactive pupils with normal pupil reflexes and normal colour vision in both eyes. The visual field to confrontation was significantly constricted. Optical coherence tomography scans demonstrated outer retinal loss in the parafoveal region with macular oedema in both eyes. An autoimmune retinopathy was suspected due to these findings. Electrodiagnostic tests were consistent with this. A secondary survey was undertaken, and a positron emission tomography scan showed no evidence of active acute myeloid leukaemia or other malignancy. Neuroimaging demonstrated generalized cortical atrophy with no acute intracranial abnormalities. He was treated for a presumed nonparaneoplastic autoimmune retinopathy. He was commenced on dexamethasone intravitreal implants and mycophenolate mofetil 1 g twice a day. At review, as well as him having multiple seborrhoeic keratoses, there was an atypical melanocytic lesion on the back, which was excised urgently. This proved to be a malignant melanoma in situ with extensive regression; subsequent re-excision revealed no residual tumour. Therefore, he was diagnosed with presumed melanoma-associated retinopathy (MAR) and commenced on monthly intravenous immunoglobulin 1.5g kg−1. On subsequent visits he subjectively felt his vision had remained stable with no further deterioration. MAR is a rare paraneoplastic ocular condition. This is an autoimmune retinopathy, where a molecular mimicry occurs between the neuroectodermally derived melanocytes and the retinal proteins. MAR can precede the diagnosis of malignant melanoma, with other initial investigations being negative. This case highlights the importance of referring patients for a thorough dermatology examination for an individual presenting with an autoimmune retinopathy. With early detection and treatment, irreversible immune-related retinal damage and associated visual loss can be mitigated.

The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease

[Ocular malignancies of xeroderma pigmentosum: clinical and therapeutic features]

Ocular Surface Side Effects of Novel Anticancer Drugs

[Ocular surface adverse reactions of antitumor-targeted drugs]

Ocular surface problems following topical medication

Review of recent advances in managing periocular skin malignancies

An Update on Oculodermal Melanocytosis and Rare Associated Conditions

Poster presentationsDS12 A rare ophthalmological consequence of cutaneous malignant melanoma

Neuro-ophthalmic complications of modern anti-cancer drugs

Ophthalmological Manifestations of Oculocutaneous and Ocular Albinism: Current Perspectives

Medical, Environmental, and Social Determinants Associated With Periocular Cutaneous Malignancies in the United States Using the All of Us National Database

Emerging Ocular Side Effects of Immune Checkpoint Inhibitors: A Comprehensive Review

Management of coexisting bilateral ocular surface disease in xeroderma pigmentosum - sequence and outcomes

Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body

Systemic diseases and the cornea

A UV-related Risk Analysis in Ophthalmic Malignancies: Increased UV Exposure May Cause Ocular Malignancies

Ocular Surface Squamous Neoplasia: Changes in the Standard of Care 2003 to 2022

Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, scleroderma, and sarcoidosis

Recent updates on ocular disease management with ophthalmic ointments

Personalized treatment concepts in extraocular cancer

Ocular Manifestations in Seborrheic Dermatitis Epidemiology, Clinical Features, and Management: A Comprehensive Review